Aptose Biosciences (APTO) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
2 Dec, 2025Executive summary
Special meeting scheduled for January 27, 2025, to be held virtually, with shareholders able to vote and ask questions online.
Main business includes a proposal for a reverse stock split and a proposal to allow adjournment of the meeting if more proxy votes are needed.
The reverse stock split aims to maintain Nasdaq listing compliance and potentially enhance share marketability.
Board recommends voting in favor of both proposals.
Proxy materials are available online and by request; voting instructions are provided for both registered and non-registered shareholders.
Voting matters and shareholder proposals
Proposal 1: Approve a reverse stock split at a ratio between 1-for-10 and 1-for-30, with the exact ratio and timing at the board's discretion.
Proposal 2: Approve adjournment of the meeting if more proxies are needed to pass Proposal 1.
Board unanimously recommends voting FOR both proposals.
Approval of Proposal 1 requires a two-thirds majority; Proposal 2 requires a simple majority.
Board of directors and corporate governance
Board has authority to determine the exact reverse split ratio and timing, and to abandon the split if deemed not in the corporation's best interest.
Directors and officers will attend the virtual meeting.
Board approved the contents and distribution of the proxy statement.
Latest events from Aptose Biosciences
- Triplet therapy delivers broad, durable AML remissions with strong safety and pivotal trials ahead.APTO
Bloom Burton & Co. Healthcare Investor Conference 202514 Mar 2026 - Board unanimously recommends approval of Hanmi’s C$2.41/share cash acquisition; insolvency risk if not approved.APTO
Proxy Filing24 Feb 2026 - Board recommends approval of C$2.41/share cash acquisition, offering a 28% premium.APTO
Proxy Filing17 Feb 2026 - Board recommends approval of Hanmi's C$2.41/share cash acquisition, offering a 28% premium.APTO
Proxy Filing9 Feb 2026 - All resolutions, including warrant share issuance, were approved by majority vote.APTO
EGM 202422 Jan 2026 - Board unanimously recommends approval of Hanmi's C$2.41/share cash acquisition; dissent rights available.APTO
Proxy Filing15 Jan 2026 - Shareholders to vote on Hanmi's C$2.41/share acquisition and Alberta continuance, with board support.APTO
Proxy Filing5 Dec 2025 - Shareholders will vote on director elections, compensation, and a reverse stock split at the May 2025 meeting.APTO
Proxy Filing2 Dec 2025 - Shareholders will vote on director elections, auditor, compensation, stock plan, and a reverse split.APTO
Proxy Filing2 Dec 2025